Background/aims Ocular surface infections remain a major cause of visual loss worldwide, yet diagnosis often relies on slow ...
Students are advised to regularly check the official CBSE website for the latest updates. The CBSE Class 10 results 2026 are expected to be released soon, based on previous years’ trends.
CBSE Class 10th result 2026: The Central Board of Secondary Education (CBSE) Class 10 board results 2026 is expected to be released soon at the official website, cbse.gov.in. While there is no ...
CBSE Result 2026 Date: Evaluation of Answer Sheets Delayed, CBSE Class 10th Results Not Anytime Soon
CBSE 10th Result 2026: The Central Board of Secondary Education is expected to announce the CBSE class 10 result 2026 by mid-April. Contrary to media reports, however, the CBSE 10th result ...
RBSE 10th Result 2026 LIVE Updates: Rajasthan Board declared results class 10 results today, 24 March, at rajeduboard.rajasthan.gov.(Hindustan Times) RBSE 10th Result 2026 LIVE Updates: The Rajasthan ...
Bihar Board 10th Result 2026 Date: The Bihar School Examination Board will announce the BSEB Class 10 result 2026 soon. According to media reports, the Bihar Board is expected to announce the Class 10 ...
The RBSE Matric results can also be checked by candidates on the HT Portal Education page. The Class 10 board exam results were announced at the press conference. This year Class 10 board examination ...
Rei Penber is the Deputy Lead Editor for GameRant's Anime and Manga team, originally from Kashmir and currently based in Beirut. He brings seven years of professional experience as a writer and editor ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
Belzutifan monotherapy in Chinese patients (pts) with von Hippel-Lindau (VHL) disease–associated tumors: Results of LITESPARK-015 study. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Report of adverse events of special interest (AESIs) for sintilimab plus a bevacizumab biosimilar (IBI305) in unresectable hepatocellular carcinoma. A multicenter study to investigate the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results